Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP) - Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)

Additional Information

Field	Value
Data last updated	October 22, 2024
Metadata last updated	October 22, 2024
Created	October 22, 2024
Format	HTML
License	Open Government Licence - Canada
Has views	False
Id	68cafe02-43a7-4e26-88eb-c2ba9da6b57c
Package id	113d0e8c-ac2d-4967-8520-36b438136c35
Position	1
State	active